TY - JOUR AU - Slamon, D. J. AU - Clark, G. M. AU - Wong, S. G. AU - Levin, W. J. AU - Ullrich, A. AU - McGuire, W. L. PY - 1987 DA - 1987// TI - Human-breast cancer-correlation of relapse and survival with amplification of the HER-2 Neu oncogene JO - Science VL - 235 UR - https://doi.org/10.1126/science.3798106 DO - 10.1126/science.3798106 ID - Slamon1987 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. H. AU - Schwartz, J. N. AU - Hagerty, K. L. AU - Allred, D. C. AU - Cote, R. J. AU - Dowsett, M. AU - Fitzgibbons, P. L. AU - Hanna, W. M. AU - Langer, A. AU - McShane, L. M. AU - Paik, S. AU - Pegram, M. D. AU - Perez, E. A. AU - Press, M. F. AU - Rhodes, A. AU - Sturgeon, C. AU - Taube, S. E. AU - Tubbs, R. AU - Vance, G. H. AU - Vijver, M. v. a. n. d. e. AU - Wheeler, T. M. AU - Hayes, D. F. PY - 2007 DA - 2007// TI - American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.2775 DO - 10.1200/JCO.2006.09.2775 ID - Wolff2007 ER - TY - JOUR AU - Aaltonen, K. AU - Amini, R. M. AU - Heikkila, P. AU - Aittomaki, K. AU - Tamminen, A. AU - Nevanlinna, H. AU - Blomqvist, C. PY - 2009 DA - 2009// TI - High cyclin B1 expression is associated with poor survival in breast cancer JO - Br J Cancer VL - 100 UR - https://doi.org/10.1038/sj.bjc.6604874 DO - 10.1038/sj.bjc.6604874 ID - Aaltonen2009 ER - TY - JOUR AU - Arora, P. AU - Cuevas, B. D. AU - Russo, A. AU - Johnson, G. L. AU - Trejo, J. PY - 2008 DA - 2008// TI - Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion JO - Oncogene VL - 27 UR - https://doi.org/10.1038/onc.2008.84 DO - 10.1038/onc.2008.84 ID - Arora2008 ER - TY - JOUR AU - Moasser, M. M. PY - 2007 DA - 2007// TI - The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210477 DO - 10.1038/sj.onc.1210477 ID - Moasser2007 ER - TY - JOUR AU - Slamon, D. J. AU - Leyland-Jones, B. AU - Shak, S. AU - Fuchs, H. AU - Paton, V. AU - Bajamonde, A. AU - Fleming, T. AU - Eiermann, W. AU - Wolter, J. AU - Pegram, M. AU - Baselga, J. AU - Norton, L. PY - 2001 DA - 2001// TI - Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200103153441101 DO - 10.1056/NEJM200103153441101 ID - Slamon2001 ER - TY - JOUR AU - Tovey, S. M. AU - Brown, S. AU - Doughty, J. C. AU - Mallon, E. A. AU - Cooke, T. G. AU - Edwards, J. PY - 2009 DA - 2009// TI - Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours JO - Br J Cancer VL - 100 UR - https://doi.org/10.1038/sj.bjc.6604940 DO - 10.1038/sj.bjc.6604940 ID - Tovey2009 ER - TY - JOUR AU - Mariani, G. AU - Fasolo, A. AU - De Benedictis, E. AU - Gianni, L. PY - 2009 DA - 2009// TI - Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer JO - Nature Clinical Practice Oncology VL - 6 UR - https://doi.org/10.1038/ncponc1298 DO - 10.1038/ncponc1298 ID - Mariani2009 ER - TY - JOUR AU - Bartlett, J. M. S. AU - Going, J. J. AU - Mallon, E. A. AU - Watters, A. D. AU - Reeves, J. R. AU - Stanton, P. AU - Richmond, J. AU - Donald, B. AU - Ferrier, R. AU - Cooke, T. G. PY - 2001 DA - 2001// TI - Evaluating HER2 amplification and overexpression in breast cancer JO - J Pathol VL - 195 UR - https://doi.org/10.1002/path.971 DO - 10.1002/path.971 ID - Bartlett2001 ER - TY - JOUR AU - Tanner, M. AU - Gancberg, D. AU - Di Leo, A. AU - Larsimont, D. AU - Rouas, G. AU - Piccart, M. J. AU - Isola, J. PY - 2000 DA - 2000// TI - Chromogenic in situ hybridization - A practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples JO - Am J Pathol VL - 157 UR - https://doi.org/10.1016/S0002-9440(10)64785-2 DO - 10.1016/S0002-9440(10)64785-2 ID - Tanner2000 ER - TY - CHAP AU - Allouche, A. AU - Nolens, G. AU - Tancredi, A. AU - Delacroix, L. AU - Mardaga, J. AU - Fridman, V. AU - Winkler, R. AU - Boniver, J. AU - Delvenne, P. AU - Begon, D. Y. PY - 2008 DA - 2008// TI - The combined immunodetection of AP-2 alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors BT - Breast Cancer Res ID - Allouche2008 ER - TY - JOUR AU - Orso, F. AU - Penna, E. AU - Cimino, D. AU - Astanina, E. AU - Maione, F. AU - Valdembri, D. AU - Giraudo, E. AU - Serini, G. AU - Sismondi, P. AU - De Bortoli, M. AU - Taverna, D. PY - 2008 DA - 2008// TI - AP-2 alpha and AP-2 gamma regulate tumor progression via specific genetic programs JO - Faseb Journal VL - 22 UR - https://doi.org/10.1096/fj.08-106492 DO - 10.1096/fj.08-106492 ID - Orso2008 ER - TY - JOUR AU - Bosher, J. M. AU - Totty, N. F. AU - Hsuan, J. J. AU - Williams, T. AU - Hurst, H. C. PY - 1996 DA - 1996// TI - A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma JO - Oncogene VL - 13 ID - Bosher1996 ER - TY - JOUR AU - Vernimmen, D. AU - Begon, D. AU - Salvador, C. AU - Gofflot, S. AU - Grooteclaes, M. AU - Winkler, R. PY - 2003 DA - 2003// TI - Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression JO - Biochemical Journal VL - 370 UR - https://doi.org/10.1042/bj20021238 DO - 10.1042/bj20021238 ID - Vernimmen2003 ER - TY - JOUR AU - Liu, X. AU - Abdelrahim, M. AU - Abudayyeh, A. AU - Lei, P. AU - Safe, S. PY - 2009 DA - 2009// TI - The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression JO - Mol Cancer Ther VL - 8 UR - https://doi.org/10.1158/1535-7163.MCT-08-1097 DO - 10.1158/1535-7163.MCT-08-1097 ID - Liu2009 ER - TY - JOUR AU - Austen, M. AU - Cerni, C. AU - Luscher-Firzlaff, J. M. AU - Luscher, B. PY - 1998 DA - 1998// TI - YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc JO - Oncogene VL - 17 UR - https://doi.org/10.1038/sj.onc.1201968 DO - 10.1038/sj.onc.1201968 ID - Austen1998 ER - TY - JOUR AU - Becker, K. G. AU - Swergold, G. D. AU - Ozato, K. AU - Thayer, R. E. PY - 1993 DA - 1993// TI - Binding of the ubiquitous nuclear transcription factor YY! to a cis regulatory sequence in the human line-1 transposable element JO - Hum Mol Genet VL - 2 UR - https://doi.org/10.1093/hmg/2.10.1697 DO - 10.1093/hmg/2.10.1697 ID - Becker1993 ER - TY - JOUR AU - Yakovleva, T. AU - Kolesnikova, L. AU - Vukojevic, V. AU - Gileva, I. AU - Tan-No, K. AU - Austen, M. AU - Luscher, B. AU - Ekstrom, T. J. AU - Terenius, L. AU - Bakalkin, G. PY - 2004 DA - 2004// TI - YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription JO - Biochem Biophys Res Commun VL - 318 UR - https://doi.org/10.1016/j.bbrc.2004.04.065 DO - 10.1016/j.bbrc.2004.04.065 ID - Yakovleva2004 ER - TY - JOUR AU - Petkova, V. AU - Romanowski, M. J. AU - Sulijoadikusumo, I. AU - Rohne, D. AU - Kang, P. AU - Shenk, T. AU - Usheva, A. PY - 2001 DA - 2001// TI - Interaction between YY1 and the retinoblastoma protein - Regulation of cell cycle progression in differentiated cells JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M007411200 DO - 10.1074/jbc.M007411200 ID - Petkova2001 ER - TY - JOUR AU - Yao, Y. L. AU - Yang, W. M. AU - Seto, E. PY - 2001 DA - 2001// TI - Regulation of transcription factor YY1 by acetylation and deacetylation JO - Mol Cell Biol VL - 21 UR - https://doi.org/10.1128/MCB.21.17.5979-5991.2001 DO - 10.1128/MCB.21.17.5979-5991.2001 ID - Yao2001 ER - TY - JOUR AU - Thomas, M. J. AU - Seto, E. PY - 1999 DA - 1999// TI - Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? JO - Gene VL - 236 UR - https://doi.org/10.1016/S0378-1119(99)00261-9 DO - 10.1016/S0378-1119(99)00261-9 ID - Thomas1999 ER - TY - JOUR AU - Gordon, S. AU - Akopyan, G. AU - Garban, H. AU - Bonavida, B. PY - 2006 DA - 2006// TI - Transcription factor YY1: structure, function, and therapeutic implications in cancer biology JO - Oncogene VL - 25 UR - https://doi.org/10.1038/sj.onc.1209080 DO - 10.1038/sj.onc.1209080 ID - Gordon2006 ER - TY - JOUR AU - Lieberthal, J. G. AU - Kaminsky, M. AU - Parkhurst, C. AU - Tanese, N. PY - 2009 DA - 2009// TI - The role of YY1 in reduced HP1 alpha gene expression in invasive human breast cancer cells JO - Breast Cancer Res VL - 11 UR - https://doi.org/10.1186/bcr2329 DO - 10.1186/bcr2329 ID - Lieberthal2009 ER - TY - JOUR AU - Wang, C. C. AU - Chen, J. J. W. AU - Yang, P. C. PY - 2006 DA - 2006// TI - Multifunctional transcription factor YY1: a therapeutic target in human cancer? JO - Expert Opinion on Therapeutic Targets VL - 10 UR - https://doi.org/10.1517/14728222.10.2.253 DO - 10.1517/14728222.10.2.253 ID - Wang2006 ER - TY - JOUR AU - Begon, D. Y. AU - Delacroix, L. AU - Vernimmen, D. AU - Jackers, P. AU - Winkler, R. PY - 2005 DA - 2005// TI - Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells JO - J Biol Chem VL - 280 UR - https://doi.org/10.1074/jbc.M503790200 DO - 10.1074/jbc.M503790200 ID - Begon2005 ER - TY - JOUR AU - Habashy, H. O. AU - Powe, D. G. AU - Rakha, E. A. AU - Ball, G. AU - Paish, C. AU - Gee, J. AU - Nicholson, R. I. AU - Ellis, I. O. PY - 2008 DA - 2008// TI - Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance JO - European Journal of Cancer VL - 44 UR - https://doi.org/10.1016/j.ejca.2008.04.020 DO - 10.1016/j.ejca.2008.04.020 ID - Habashy2008 ER - TY - JOUR AU - El-Rehim, D. M. A. AU - Ball, G. AU - Pinder, S. E. AU - Rakha, E. AU - Paish, C. AU - Robertson, J. F. R. AU - Macmillan, D. AU - I, R. W. B. AU - Ellis, I. O. PY - 2005 DA - 2005// TI - High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses JO - Int J Cancer VL - 116 UR - https://doi.org/10.1002/ijc.21004 DO - 10.1002/ijc.21004 ID - El-Rehim2005 ER - TY - JOUR AU - McCarty, K. S. AU - Miller, L. S. AU - Cox, E. B. AU - Konrath, J. AU - McCarty, K. S. PY - 1985 DA - 1985// TI - Estrogen-Receptor Analyses - Correlation of Biochemical and Immunohistochemical Methods Using Monoclonal Antireceptor Antibodies JO - Archives of Pathology & Laboratory Medicine VL - 109 ID - McCarty1985 ER - TY - JOUR AU - El-Rehim, D. AU - Ball, G. AU - Pinder, S. AU - Rakha, E. AU - Paish, C. AU - Robertson, J. AU - Macmillan, D. AU - Blamey, R. AU - Ellis, I. PY - 2005 DA - 2005// TI - High throughput protein expression analysis using tissue microarray technology of a large well -characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses JO - Int J Cancer VL - 116 UR - https://doi.org/10.1002/ijc.21004 DO - 10.1002/ijc.21004 ID - El-Rehim2005 ER - TY - JOUR AU - El-Rehim, D. M. A. AU - Pinder, S. E. AU - Paish, C. E. AU - Bell, J. AU - Blamey, R. AU - Robertson, J. F. R. AU - Nicholson, R. I. AU - Ellis, I. O. PY - 2004 DA - 2004// TI - Expression of luminal and basal cytokeratins in human breast carcinoma JO - Journal of Pathology VL - 203 UR - https://doi.org/10.1002/path.1559 DO - 10.1002/path.1559 ID - El-Rehim2004 ER - TY - JOUR AU - Friedrichs, N. AU - Jager, R. AU - Paggen, E. AU - Rudlowski, C. AU - Merkelbach-Bruse, S. AU - Schorle, H. AU - Buettner, R. PY - 2005 DA - 2005// TI - Distinct spatial expression patterns of AP-2alpha and AP-2 gamma in non-neoplastic human breast and breast cancer JO - Mod Pathol VL - 18 UR - https://doi.org/10.1038/modpathol.3800292 DO - 10.1038/modpathol.3800292 ID - Friedrichs2005 ER - TY - JOUR AU - Gee, J. M. W. AU - Robertson, J. F. R. AU - Ellis, I. O. AU - Nicholson, R. I. AU - Hurst, H. C. PY - 1999 DA - 1999// TI - Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer JO - J Pathol VL - 189 UR - https://doi.org/3.0.CO;2-9 DO - 3.0.CO;2-9 ID - Gee1999 ER - TY - JOUR AU - Pellikainen, J. AU - Kataja, V. AU - Ropponen, K. AU - Kellokoski, J. AU - Pietilainen, T. AU - Bohm, J. AU - Eskelinen, M. AU - Kosma, V. M. PY - 2002 DA - 2002// TI - Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer JO - Clin Cancer Res VL - 8 ID - Pellikainen2002 ER - TY - JOUR AU - Orso, F. AU - Cottone, E. AU - Hasleton, M. D. AU - Ibbitt, J. C. AU - Sismondi, P. AU - Hurst, H. C. AU - De Bortoli, M. PY - 2004 DA - 2004// TI - Activator protein-2 gamma (AP-2 gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5 '-untranslated region JO - Biochemical Journal VL - 377 UR - https://doi.org/10.1042/bj20031133 DO - 10.1042/bj20031133 ID - Orso2004 ER - TY - JOUR AU - Zhang, X. AU - Leung, Y. K. AU - Ho, S. M. PY - 2007 DA - 2007// TI - AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210537 DO - 10.1038/sj.onc.1210537 ID - Zhang2007 ER - TY - JOUR AU - Turner, B. C. AU - Zhang, J. AU - Gumbs, A. A. AU - Maher, M. G. AU - Kaplan, L. AU - Carter, D. AU - Glazer, P. M. AU - Hurst, H. C. AU - Haffty, B. G. AU - Williams, T. PY - 1998 DA - 1998// TI - Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways JO - Cancer Res VL - 58 ID - Turner1998 ER - TY - JOUR AU - Gee, J. M. W. AU - Eloranta, J. J. AU - Ibbitt, J. C. AU - Robertson, J. F. R. AU - Ellis, I. O. AU - Williams, T. AU - Nicholson, R. I. AU - Hurst, H. C. PY - 2009 DA - 2009// TI - Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival JO - J Pathol VL - 217 UR - https://doi.org/10.1002/path.2430 DO - 10.1002/path.2430 ID - Gee2009 ER - TY - JOUR AU - McPherson, L. A. AU - Loktev, A. V. AU - Weigel, R. J. PY - 2002 DA - 2002// TI - Tumor suppressor activity of AP2 alpha mediated through a direct interaction with p53 JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M208924200 DO - 10.1074/jbc.M208924200 ID - McPherson2002 ER - TY - JOUR AU - Schwartz, B. AU - Melnikova, V. O. AU - Tellez, C. AU - Mourad-Zeidan, A. AU - Blehm, K. AU - Zhao, Y. J. AU - McCarty, M. AU - Adam, L. AU - Bar-Eli, M. PY - 2007 DA - 2007// TI - Loss of AP-2 alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210193 DO - 10.1038/sj.onc.1210193 ID - Schwartz2007 ER - TY - JOUR AU - Korkola, J. E. AU - DeVries, S. AU - Fridlyand, J. AU - Hwang, E. S. AU - Estep, A. L. AU - Chen, Y. Y. AU - Chew, K. L. AU - Dairkee, S. H. AU - Jensen, R. M. AU - Waldman, F. M. PY - 2003 DA - 2003// TI - Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis JO - Cancer Res VL - 63 ID - Korkola2003 ER -